Share Name Share Symbol Market Type Share ISIN Share Description
Advanced Medical Solutions LSE:AMS London Ordinary Share GB0004536594 ORD 5P
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  -5.75p -1.80% 313.75p 313.00p 313.75p 321.25p 312.75p 315.50p 369,979 16:35:07
Industry Sector Turnover (m) Profit (m) EPS - Basic PE Ratio Market Cap (m)
Health Care Equipment & Services 82.6 19.1 7.5 41.9 655.97

Advanced Medical Solutions Share Discussion Threads

Showing 7001 to 7025 of 7025 messages
Chat Pages: 281  280  279  278  277  276  275  274  273  272  271  270  Older
DateSubjectAuthorDiscuss
14/11/2017
13:15
No buyers in sight so share price drops on pitiful volume.
wetdream
10/11/2017
10:35
Markets very nervous imho.
wetdream
05/11/2017
10:41
Next trading update should be mid December.
potty punter
30/10/2017
15:09
Yes indeed `malcontent` highest ever share price today. Where to now, are we a target for the big boys?
dealit
30/10/2017
14:09
this one is out of the traps again and at a gallop what a stock
malcontent
27/10/2017
11:09
SP holding up well, given volume of sells-and it's a Friday.....
wetdream
27/10/2017
11:00
http://www.organogenesis.com/news/press-announcements.html
mirandaj
26/10/2017
22:51
Cgequityinvest, Couldn't agree more. It's the US link up that's more important (ok, the money's important too, but AMS is pretty cash-rich already). Traditionally, US cos will do their best to link up with other US cos first. It's a feather in AMS's cap that they've made this move.
wetdream
26/10/2017
16:34
Ok, thanks cge, makes sense..
ilovefrogs
26/10/2017
16:04
I think the upside comes from :- * the income is a royalty stream so it should fall largely through to the bottom line. i.e. i would expect the margin to be very high. Based on brokers expectations of £18.1m net profit for y/e Dec, the payment of $2.5m (say £1.9m equiv) could increase eps by nearly 10% (assuming minimal costs to be offset). This equates closely with the circa 9% price increase today. * strategically its another key step in the US and will help further establish their presence over there. The US company looks a bit small to be a potential purchaser of AMS - its not publically quoted at present. will be interesting to see what revised forecasts emerge from the brokers over the next week or so. Still at a high p/e multiple but this is a quality business with a long, strong track record of growth and cash generation.
cgequityinvest
26/10/2017
14:13
Anyone know just how significant the RNS is. Doesn't give any indications of revenue above agreed minimums (which are small in the scheme of things)
ilovefrogs
26/10/2017
12:47
http://www.cardinalhealth.com/content/dam/corp/web/documents/brochure/cardinal-health-liquiband-octyl-topical-skin-adhesive-brochure.pdf http://www.cardinalhealth.com/en/product-solutions/medical/skin-and-wound-management/surgical-wound-closure/liquiband--octyl-topical-skin-adhesive.html For interest
mirandaj
26/10/2017
11:31
S/P moved North on the announcement today.
dealit
19/9/2017
10:38
Steady buyback of own shares, and organic growth through own product development . Markets are frothy , takeovers are risky
norbus
18/9/2017
14:00
It will be interesting to see what the company decide to do with all their(our) cash- special dividend would be most welcome....
malcontent
15/9/2017
16:08
Looks like about 40p in the 320p was 'froth'. Still not clear to me what the 'market' was expecting to provke such a sell-off, apart from a general nervousness.
wetdream
13/9/2017
17:34
I agree that price maybe got ahead of itself. Results were solid but of course boosted by one off favourable currency movements - stripping this out turnover was up by only 8%. A number of stocks with large dollar receipts have seen some pull back given the recent weakness of the dollar v sterling Also remember that share price had improved circa 40% this year - against a circa 20% eps growth. I am a big fan of the company having been a holder for a number of years but it is now trading on pretty high p/e and absent a bid approach the share price may be due a period of consolidation. Management seem to be taking a pretty cautious approach to acquisitions - maybe no bad thing. I think they could be a bit more aggressive in hiking the dividend given the cash on the balance sheet.
cgequityinvest
13/9/2017
16:06
Pricey P/E; will catch up, but liquiband may not be big enough driver of growth at the size. doing great but ran ahead of itself
norbus
13/9/2017
15:46
Perhaps there'll be press comment tomorrow as to why the results were so 'disappointing'?
wetdream
13/9/2017
14:20
What does a Company have to do to please the market, the results are good 54m in the bank all divisions increased profits including US and an increase in the dividend. I can only feel that the MM`s are playing games with AMS shares, i.e. get the price down to fill orders, IMHO.
dealit
13/9/2017
07:07
Market not impressed apparently. Lots of 'O' trade sells (PIs?). Wonder what they expected?
wetdream
13/9/2017
06:27
Good solid set of results out today increased dividend, lets hope the market agrees.
dealit
20/6/2017
13:59
I am with you on the diworsifying. Though better to feel 😄 about the shares I still hold from 8p.
snape
16/6/2017
16:29
My only regret is diworsifying over the years ... LOL
pedr01
16/6/2017
15:42
£3 getting very close now, Director sell shares and the price goes up happy days indeed.
dealit
Chat Pages: 281  280  279  278  277  276  275  274  273  272  271  270  Older
Your Recent History
LSE
GKP
Gulf Keyst..
LSE
QPP
Quindell
FTSE
UKX
FTSE 100
LSE
IOF
Iofina
FX
GBPUSD
UK Sterlin..
Stocks you've viewed will appear in this box, letting you easily return to quotes you've seen previously.

Register now to create your own custom streaming stock watchlist.

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

P:43 V: D:20171119 10:24:17